The electronic aggregometer: a novel device for assessing platelet behavior in blood

Area of Science:

• Biomedical Engineering
• Hematology
• Pharmacology

Background:

• Platelet aggregation is crucial for hemostasis and thrombosis.
• Accurate measurement of platelet aggregation is essential for diagnosing and managing bleeding disorders and thrombotic events.
• Existing methods for measuring platelet aggregation have limitations.

Purpose of the Study:

• To introduce a novel device for measuring platelet aggregation.
• To evaluate the suitability of this device for use with platelet-rich plasma (PRP) and whole blood.
• To assess the device's utility in platelet pharmacology studies.

Main Methods:

• A new device measuring changes in electrical impedance due to platelet accretion on electrodes was developed.
• The device was tested using various agonists (collagen, thrombin, prostaglandin endoperoxides, ADP, arachidonic acid) in both PRP and whole blood.
• Responses were compared to traditional turbidometric methods.

Main Results:

• The electronic aggregometer showed similar dose-related responses to agonists in PRP and whole blood compared to turbidometry.
• The electronic method was more sensitive than turbidometry in PRP.
• The device provided no "shape-change" information.
• The technique proved effective for quantifying aggregation inhibitors like indomethacin and prostacyclin in blood.

Conclusions:

• The novel electronic impedance device offers a sensitive and suitable method for measuring platelet aggregation in both PRP and whole blood.
• This technique is valuable for platelet pharmacology, enabling convenient quantification of aggregation inhibitors.
• The device complements existing methods by offering enhanced sensitivity for certain applications.